N
1.19
0.01 (0.86%)
| Previous Close | 1.18 |
| Open | 1.17 |
| Volume | 59,477 |
| Avg. Volume (3M) | 477,054 |
| Market Cap | 2,561,930 |
| Price / Earnings (TTM) | 0.041 |
| Price / Sales | 0.010 |
| Price / Book | 7.15 |
| 52 Weeks Range |
| Profit Margin | -9.66% |
| Operating Margin (TTM) | -85.51% |
| Diluted EPS (TTM) | -293.10 |
| Quarterly Revenue Growth (YOY) | -16.20% |
| Current Ratio (MRQ) | 1.17 |
| Operating Cash Flow (TTM) | -8.26 M |
| Return on Assets (TTM) | -17.99% |
| Return on Equity (TTM) | -53.76% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | NewGenIvf Group Limited | - | - |
AIStockmoo Score
-0.1
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.13 |
|
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| % Held by Insiders | 2.24% |
| % Held by Institutions | 0.55% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Marex Group Plc | 30 Jun 2025 | 2,010 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 20 Oct 2025 | Announcement | NewGen Announces Strategic Entry into Art Tokenization Market with $2 Million Private Collection Deal, Expandable to $200 Million |
| 10 Oct 2025 | Announcement | Zacks Small-Cap Research Initiates Coverage on NewGen |
| 08 Oct 2025 | Announcement | NewGen Establishes New Joint Venture Dedicated to Real Estate Development in UAE |
| 06 Oct 2025 | Announcement | NewGen Reports Total Gain from IP Acquisition of $17.9 Million for FY 2025 |
| 29 Jul 2025 | Announcement | NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |